Cimetidine therapy for epidermodysplasia verruciformis

Journal of the American Academy of Dermatology

Volumn 48, Issue 2, 2003, Pages

  Micali, Giuseppe ^a   Nasca, Maria Rita ^a   Dall'Oglio, Federica ^a   Letizia Musumeci, Maria ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE;

ADOLESCENT; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CASE REPORT; CLINICAL FEATURE; EPIDERMODYSPLASIA VERRUCIFORMIS; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERKERATOSIS; INFECTION SENSITIVITY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIDE EFFECT; SKIN BIOPSY; TREATMENT OUTCOME; VIRUS DIAGNOSIS; WART VIRUS;

EID: 0037324345     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2003.111     Document Type: Article

References (17)

1. Ramoz N, Rueda LA, Bouadjar B, Favre M, Orth G. A susceptibility locus for epidermodysplasia verruciformis, an abnormal predisposition to infection with the oncogenic human papillomavirus type 5, maps to chromosome 17qter in a region containing a psoriasis locus. J Invest Dermatol 1999;112:259-63.
2. Majewski S, Jablonska S. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin. Arch Dermatol 1995;131:1312-8.
3. Majewski S, Jablonska S. Human papillomavirus-associated tumors of the skin and mucosa. J Am Acad Dermatol 1997;36:659-85.
4. Kanerva LO, Johansson E, Niemi KM, Lauharanta J, Salo OP. Epidermodysplasia verruciformis: clinical and light- and electron-microscopic observations during etretinate therapy. Arch Dermatol Res 1985;278:153-60.
5. Kowalzick L, Mensing H. Failure of etretinate in epidermodysplasia verruciformis. Dermatologica 1986;173:75-8.
6. Androphy EJ, Dvoretzky I, Maluish AE, Wallace HJ, Lowy DR. Response of warts in epidermodysplasia verruciformis to treatment with systemic and intralesional alpha interferon. J Am Acad Dermatol 1984;11:197-202.
7. Orlow SJ, Paller A. Cimetidine therapy for multiple warts in children. J Am Acad Dermatol 1993;28:794-6.
8. Glass AT, Solomon BA. Cimetidine therapy for recalcitrant warts in adults. Arch Dermatol 1996;132:680-2.
9. de Prost Y, Paquez F, Touraine R. Dinitrochlorobenzene treatment of alopecia areata. Arch Dermatol 1982;118:542-5.
10. Simon MR, Salberg DJ, Crane SA. In vivo cimetidine augmentation of phytohemagglutinin-induced human lymphocyte thymidine uptake. Transplantation 1981;31:400-2.
11. Sahasrabudhe DM, McCune CS, O'Donnell RW, Henshaw EC. Inhibition of suppressor T lymphocytes (Ts) by cimetidine. J Immunol 1987;138:2760-3.
12. Yilmaz E, Alpsoy E, Basaran E. Cimetidine therapy for warts: a placebo-controlled, double-blind study. J Am Acad Dermatol 1996;34:1005-7.
13. Bauman C, Francis JS, Vanderhooft S, Sybert VP. Cimetidine therapy for multiple warts in children. J Am Acad Dermatol 1996;35:271-2.
14. Karabulut AA, Sahin S, Eksioglu M. Is cimetidine effective for nongenital warts: a double-blind, placebo-controlled study. Arch Dermatol 1997; 133:533-4.
15. Fischer G, Rogers M. Cimetidine therapy for warts in children. J Am Acad Dermatol 1997;37:289-90.
16. Saenz-Santamaria MC, Gilabert Y. Cimetidine and warts. Arch Dermatol 1997;133:530.
17. Rogers CJ, Gibney MD, Siegfried EC, Harrison BR, Glaser DA. Cimetidine therapy for recalcitrant warts in adults: is it any better than placebo? J Am Acad Dermatol 1999;41:123-7.